Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-06-14 | 2017-06-22 | 12745 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2018-09-07 | 2018-11-22 | 60200 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96874 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2020-02-27 | 2020-03-27 | 107296 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96880 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80863 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-21 | 2020-05-28 | 99480 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198795 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-26 | 2024-04-23 | 220656 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80866 |
| TELMISARTAN | 40MG | TABLET | Resolved | 2019-06-10 | 2019-07-20 | 86050 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |